Roche Canada and Alberta Cancer Foundation partner to improve outcomes for Albertans facing a cancer diagnosis

April 24, 2025 (Edmonton, Alberta) The Alberta Cancer Foundation and Hoffmann-La Roche Limited (Roche Canada) have announced a new partnership that will see the global life sciences company redirect $1 million of its investment with the Foundation towards new programs in Cancer Care Alberta that will directly impact the lives of Albertans facing cancer.

This investment will target three specific areas of focus in Alberta:

“We are fortunate to have such a long-standing partnership with Roche Canada and are incredibly grateful they’ve chosen to make this significant reinvestment in cancer care, right here in Alberta,” said Wendy Beauchesne, CEO of the Alberta Cancer Foundation. “This will ignite our cancer research and care teams to do what they do best — be curious and drive change.”

“At Roche Canada, we recognize the power of collaboration in addressing patient needs and driving meaningful change for Canadians,” said Brigitte Nolet, President and CEO, Roche Pharma Canada. “Our partnership with the Alberta Cancer Foundation and Cancer Care Alberta will have a ripple effect — strengthening our healthcare systems, boosting economic growth and improving outcomes for patients.”

Roche Canada’s previous commitment to the Alberta Cancer Foundation enabled translational impact to be made in the areas of thoracis, palliative care and breast cancer research. This reinvestment broadens that impact and will address the future of cancer care – today.

“We’re so grateful for this support from Roche Canada and the Alberta Cancer Foundation – it truly strengthens Cancer Care Alberta’s work,” said Brenda Hubley, Chief Program Officer with Cancer Care Alberta. “It means our dedicated teams can collaborate more easily and use information to improve cancer care experiences. We can spark innovation, ultimately helping more Albertans facing cancer live longer, better lives.”

The Alberta Cancer Foundation represents a community of 100,000+ donors who want to provide more moments for Albertans facing a cancer diagnosis. The Foundation is the official fundraising partner for every cancer centre in the province, empowering and uniting Albertans around a common purpose, investing in the future of cancer research and care, and ensuring no Albertan facing cancer walks alone.

For more information visit albertacancer.ca

At Roche Canada, patients and science are at the heart of everything we do. Our passion for science and our commitment to relentlessly pursuing the impossible for patients have made us one of the world’s leading pharmaceutical, in-vitro diagnostics, and diabetes care management companies.

With our combined strength in diagnostics and pharmaceuticals, we’re driving healthcare forward, while ensuring we deliver meaningful benefits for patients and sustainable healthcare systems. We are committed to creating a world where we all have more time with the people we love.

And we’re adding our expertise in new areas, such as artificial intelligence, real world data collection and analysis and collaborating with many different sectors and industries.

Having the courage to reinvent ourselves and question the status quo is what patients and healthcare systems expect from Roche – and our commitment is as strong today as it was on the first day of our Canadian journey in 1931. Today, Roche Canada employs nearly 2,000 people at its offices in Mississauga, Ontario, in Laval, Quebec, and across the country from coast to coast to coast.

For more information, please visit www.RocheCanada.com or follow Roche Canada on LinkedIn.